No Harmful Actions. If a Party believes that the other Party is taking or intends to take any action with respect to a Product that could reasonably be expected to have a material adverse impact upon the regulatory status of such Product in the first Party’s territory, then such Party may bring the matter to the attention of the JDC and the Parties shall discuss in good faith to resolve such concern.
Appears in 6 contracts
Samples: Collaboration and License Agreement (Exelixis, Inc.), Collaboration and License Agreement (Exelixis, Inc.), Collaboration and License Agreement (Exelixis, Inc.)
No Harmful Actions. If a either Party believes that the other Party Party, as the case may be, is taking or intends to take any action with respect to a the Product that could reasonably be expected to have a material adverse impact upon the regulatory status of such the Product in the first Party’s territoryRetained Territory or the Licensed Territory, then such Party may shall have the right to bring the matter to the attention of the JDC and the Parties shall discuss in good faith to resolve such concernJDC.
Appears in 3 contracts
Samples: License and Collaboration Agreement (Five Prime Therapeutics Inc), License and Collaboration Agreement (Five Prime Therapeutics Inc), License and Collaboration Agreement (Five Prime Therapeutics Inc)
No Harmful Actions. If a Party reasonably believes that the other Party is taking or intends to take any action with respect to a Product that could reasonably be expected to have a material adverse impact upon the regulatory status of such Product in the first Party’s territory, then such Party may bring the matter to the attention of the JDC JSC and the Parties shall discuss in good faith to promptly resolve such concern.
Appears in 2 contracts
Samples: Exclusive Commercialization License Agreement (Rigel Pharmaceuticals Inc), Collaboration and License Agreement (Rigel Pharmaceuticals Inc)
No Harmful Actions. If a Party believes that the other Party is taking or intends to take any action with respect to a any Product that could reasonably be expected to have a material adverse impact upon the Development, Manufacture, Commercialization or regulatory status of such any Product in the first other Party’s territoryTerritory, then such the impacted Party may bring the matter to the attention of the JDC JSC and the Parties shall discuss in good faith to promptly resolve such concern.
Appears in 1 contract
Samples: Development and Manufacturing Collaboration Agreement (Vir Biotechnology, Inc.)
No Harmful Actions. If a Party believes that the other Party is taking or intends to take any action with respect to a any Product that could reasonably [*] be expected to have a material adverse impact upon the regulatory status of such the Product in the first Party’s its territory, then such Party may bring the matter to the attention of the JDC JSC and the Parties shall discuss in good faith [*] to [*] resolve such concern.
Appears in 1 contract
Samples: License and Collaboration Agreement (C4 Therapeutics, Inc.)
No Harmful Actions. If a Party reasonably believes that the other Party is taking or intends to take any action with respect to a Product that could reasonably be expected to have a material adverse impact upon the regulatory status status, approval, labeling, safety, market clearance, or the ability of such Party to sell, market, Develop, or Commercialize any Product in the first such Party’s territoryTerritory, then such Party may bring the matter to the attention of the JDC JSC and the Parties JSC shall discuss such concern in good faith to resolve such concernfaith.
Appears in 1 contract
No Harmful Actions. If a Party reasonably believes that the other Party is taking or intends to take any action with respect to a Product that could reasonably be expected to have a material adverse impact upon the regulatory status of such any Product in the first such Party’s territoryTerritory, then such Party may bring the matter to the attention of the JDC JSC and the Parties shall discuss seek in good faith to promptly resolve such concern.
Appears in 1 contract
Samples: Exclusive License and Collaboration Agreement (Forty Seven, Inc.)
No Harmful Actions. If a either Party believes that the other Party is taking or intends to take any action with respect to a Product that could reasonably be expected to have a material adverse impact upon the regulatory status of such the Product in the first Party’s outside its respective territory, then such Party may has the right to bring the matter to the attention of the JDC and the Parties shall will discuss in good faith to resolve such concern.
Appears in 1 contract
Samples: License Agreement (Turning Point Therapeutics, Inc.)
No Harmful Actions. If a either Party believes that the other Party is taking or intends to take any action with respect to a any Licensed Product that could reasonably be expected to have a material adverse impact upon the regulatory status of such Product an Adverse Risk, whether in the first Party’s territoryGenfit Territory or in the Terns Territory, then such Party may bring the matter to the attention of the JDC JSC and the Parties shall discuss in good faith to promptly resolve such concern.
Appears in 1 contract
No Harmful Actions. If a Party believes that the other Party is taking or intends to take any action with respect to a Product that could reasonably be expected to have a material adverse impact upon the regulatory status of such Product in the first Party’s territory, then such Party may bring the matter to the attention of the JDC and the Parties shall discuss in good faith to resolve such concern.. 5.7
Appears in 1 contract
Samples: Collaboration and License Agreement
